Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome

Erin M. Parry; Jennifer R. Brown; Neil E. Kay; Chip Stewart; Kahn Rhrissorrakrai; Donna Neuberg; Stacey M. Fernandes; Sameer A. Parikh; Julien Broséus; Laura Z. Rassenti; Florence Cymbalista; Robert Redd; Conor Messer; Ziao Lin; Nitin Jain; Aina Zurita Martinez; Raquel A. Jacobs; Eugen Tausch; Romain Guièze; Annabelle Anandappa; Noelia Purroy; Thomas J. Kipps; Stephanie Deng; Brian P. Danysh; Camilla K. Lemvigh; Jialin Ma; Kenneth J. Livak; Chaya Levovitz; Binyamin A. Knisbacher; Ignaty Leshchiner; Kara Slowik; Matthew S. Davids; Julian M. Hess; Pierre Feugier; Daniel Rosebrock; Filippo Utro; Shanye Yin; Liudmila Elagina; Bria Persaud; Amaro Taylor‐Weiner; Sébastien Hergalant; Teddy Huang; Christof Schneider; William G. Wierda; Neil Ruthen; Liang Li; Connor Johnson; Shuqiang Li; Geoff Fell; Dimitri Livitz

doi:10.1038/s41591-022-02113-6

Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome

Erin M. Parry(Broad Institute), Jennifer R. Brown(Dana-Farber Cancer Institute), Neil E. Kay(Mayo Clinic), Chip Stewart(Broad Institute), Kahn Rhrissorrakrai(IBM (United States)), Donna Neuberg(Otsuka (Japan)), Stacey M. Fernandes(Dana-Farber Cancer Institute), Sameer A. Parikh(Mayo Clinic), Julien Broséus(Inserm), Laura Z. Rassenti(University of California San Diego), Florence Cymbalista(Hôpital Avicenne), Robert Redd(Harvard University), Conor Messer(Broad Institute), Ziao Lin(Broad Institute), Nitin Jain(Parul University), Aina Zurita Martinez(Broad Institute), Raquel A. Jacobs(Broad Institute), Eugen Tausch(Universität Ulm), Romain Guièze(Broad Institute), Annabelle Anandappa(Harvard University), Noelia Purroy(Universitat Autònoma de Barcelona), Thomas J. Kipps(University of California San Diego), Stephanie Deng(Dana-Farber Cancer Institute), Brian P. Danysh(Broad Institute), Camilla K. Lemvigh(Technical University of Denmark), Jialin Ma(Broad Institute), Kenneth J. Livak(Broad Institute), Chaya Levovitz(IBM (United States)), Binyamin A. Knisbacher(Broad Institute), Ignaty Leshchiner(Broad Institute), Kara Slowik(Broad Institute), Matthew S. Davids(Dana-Farber Cancer Institute), Julian M. Hess(Broad Institute), Pierre Feugier(Inserm), Daniel Rosebrock(Broad Institute), Filippo Utro(IBM (United States)), Shanye Yin(Albert Einstein College of Medicine), Liudmila Elagina(Broad Institute), Bria Persaud(Broad Institute), Amaro Taylor‐Weiner(Critical Path Institute), Sébastien Hergalant(Inserm), Teddy Huang(Dana-Farber Cancer Institute), Christof Schneider(Universität Ulm), William G. Wierda(University of Maryland, Baltimore), Neil Ruthen(Dana-Farber Cancer Institute), Liang Li(Chengdu University), Connor Johnson(Broad Institute), Shuqiang Li(Dana-Farber Cancer Institute), Geoff Fell(Dana-Farber Cancer Institute), Dimitri Livitz(Broad Institute)

Nature Medicine

January 1, 2023

10.1038/s41591-022-02113-6

Cited by 83

Related Papers

Next-generation characterization of the Cancer Cell Line Encyclopedia

|Nature|2019|3.7k

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines

|Blood|2008|3.2k

Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients

|Cell|2015|2.4k

Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia

|New England Journal of Medicine|2013|2.2k

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

|Molecular Cancer|2023|1.9k